SBIR/STTR Research Award

Fully defined matrices for organoid culture

Award identifier 607440c5bf25c934fabbeab4995b2e339f66d2be55c628aba2a4ea17618edd67Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$290,768

Program and phase

SBIR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
INSOMA BIO, INC.
Proposal award date
2021-09-21
Contract end date
2022-08-31
UEI
LF3PGT7RN6G7
Solicitation number
PA20-260
Topic code
300

Research abstract

Project SummaryCompared to standard two dimensional methods, three dimensional cell culture presents an opportunity to more reliably replicate and model in vivo physiology under controlled laboratory conditions. Organoid culture in particular has been shown to replicate in vivo tissue development, differentiation, and disease physiology in many cases. Recent reports however indicate that current cell culture substrates, including Matrigel, collagen and other recombinant extracellular matrix components, trigger undesirable phenotypes for modeling normal tissue function using cultured organoids. Here, we propose a collaborative Phase I program to expand the utility of inSoma’s proprietary Partially Ordered Polymers (POPs) in three-dimensional organoid culture with Scott Magness, PhD of the University of North Carolina at Chapel Hill, a leading expert in modeling gastrointestinal tissues using three dimensional culture systems. Our proof-of-concept program is intended to optimize POP formulations for three-dimensional culture, evaluate their support of organoid viability and proliferation, and employ transcriptomics to determine if aberrant phenotypes are reduced compared to other matrices, such as Matrigel. Once we establish lead formulations of the POP material for organoid culture, a Phase II program would evaluate organoids from other tissue types, including neural, pancreatic and liver tissues as well as potential testing of POPs as a support matrix for in vivo tissue engineering approaches. Each of these product classes has unique markets in both academic research, pharmaceutical screening and tissue engineering. inSoma has a robust intellectual property estate on POP biomaterials and given the rapid growth of three-dimensional culture for modeling in vivo physiology, we anticipate the product to address a significant market in the life science tools sector with specific advantages over market leaders such as Matrigel.Project NarrativeThree-dimensional cell culture has become a powerful means of replicating in vivo physiology under controlled in vitro conditions. Substrates for three-dimensional culture, such as Matrigel, remain undefined and highly variable however, leading to a wide variation in cellular phenotypes. Partially ordered polymers (POPs) from inSoma function as a fully-defined three-dimensional culture matrix. This material is made from recombinant proteins, allowing for reliable and consistent manufacturing methods, and has been shown to support cellular viability in culture. Here we propose to evaluate this material for both organoid and stem cell culture, large markets which urgently require a new option for more defined cell culture conditions.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

8 SBIR/STTR records share this UEI (2019–2024). Reported award amounts total $4,622,787. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.